These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
584 related items for PubMed ID: 12453314
1. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Brühlmann P, Müller-Ladner U, Gay S, Matucci-Cerinic M. Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314 [Abstract] [Full Text] [Related]
3. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Riccieri V, Stefanantoni K, Vasile M, Macrì V, Sciarra I, Iannace N, Alessandri C, Valesini G. Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218 [Abstract] [Full Text] [Related]
4. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus. Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T. Lupus; 2002; 11(6):348-55. PubMed ID: 12139372 [Abstract] [Full Text] [Related]
5. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors. Miyashita M, Tajiri T, Yanagi K, Shimizu T, Futami R, Sasajima K, Tokunaga A. Hepatogastroenterology; 2003; 50(50):308-9. PubMed ID: 12749209 [Abstract] [Full Text] [Related]
6. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, Kohno H, Nagasue N. Cancer; 2002 Nov 15; 95(10):2188-95. PubMed ID: 12412173 [Abstract] [Full Text] [Related]
9. Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis. Silva I, Almeida C, Teixeira A, Oliveira J, Vasconcelos C. Clin Rheumatol; 2016 Jul 15; 35(7):1743-51. PubMed ID: 26920752 [Abstract] [Full Text] [Related]
11. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B. Arthritis Rheum; 2000 Apr 15; 43(4):889-93. PubMed ID: 10765935 [Abstract] [Full Text] [Related]
12. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Proc Natl Acad Sci U S A; 2001 May 22; 98(11):6470-5. PubMed ID: 11353854 [Abstract] [Full Text] [Related]
13. Serum angiogenic activity: diagnostic relevance in renal cell carcinoma. Beecken WD, Bentas W, Glienke W, Linneweber J, Jonas D, Binder J, Kramer W. Eur Urol; 2002 Oct 22; 42(4):364-9. PubMed ID: 12361902 [Abstract] [Full Text] [Related]
14. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Feldman AL, Alexander HR, Yang JC, Linehan WM, Eyler RA, Miller MS, Steinberg SM, Libutti SK. Cancer; 2002 Oct 15; 95(8):1637-43. PubMed ID: 12365010 [Abstract] [Full Text] [Related]
15. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity. Michalska-Jakubus M, Cutolo M, Smith V, Krasowska D. Microvasc Res; 2019 Sep 15; 125():103881. PubMed ID: 31075243 [Abstract] [Full Text] [Related]
16. Dysregulation of angiogenic homeostasis in systemic sclerosis. Farouk HM, Hamza SH, El Bakry SA, Youssef SS, Aly IM, Moustafa AA, Assaf NY, El Dakrony AH. Int J Rheum Dis; 2013 Aug 15; 16(4):448-54. PubMed ID: 23992267 [Abstract] [Full Text] [Related]
18. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Feldman AL, Alexander HR, Bartlett DL, Kranda KC, Miller MS, Costouros NG, Choyke PL, Libutti SK. Ann Surg Oncol; 2001 Oct 15; 8(9):741-5. PubMed ID: 11597016 [Abstract] [Full Text] [Related]
19. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy. Gigante A, Navarini L, Margiotta D, Amoroso A, Barbano B, Cianci R, Afeltra A, Rosato E. Microvasc Res; 2017 Nov 15; 114():41-45. PubMed ID: 28602918 [Abstract] [Full Text] [Related]